Jusino-Berrios Carlos M

Jusino-Berrios Carlos M, a Hispanic American-owned, minority-owned sole proprietor based in Jersey City, New Jersey, provides medical consultant services for disability adjudication and claim file reviews exclusively to the Social Security Administration as a prime contractor on BPA call orders, with no subcontract work. The vendor operates as a self-certified small disadvantaged business competing exclusively in full-and-open (non-set-aside) procurements, though one historical call order from 2022 carried a Total Small Business set-aside designation.

The vendor's entire portfolio—all 55 awards spanning from 1997 to June 2026—derives from a single customer: the Social Security Administration. Work centers on independent medical case reviews for the agency's disability programs, primarily in the Northeast region (New York regional office and Region 2 coverage) with performance locations also including Baltimore, Maryland and Pompano Beach, Florida. NAICS coding reflects the medical consultant focus: 43 awards fall under Offices of Physicians and Mental Health Specialists, with 10 additional awards under Offices of Physicians excluding mental health specialists. PSC coding emphasizes Medical-Medical/Psychiatric Consultation (25 awards) and Support-Professional Expert Witness services (12 awards).

Recent work has concentrated on four active BPAs. The largest volume sits on Blanket Purchase Agreement 28321321AC0240013 ($2.138 million umbrella), which generated 8 task orders valued at $980 thousand combined. The vendor also places significant work on Blanket Purchase Agreement SS021140086 (16 task orders, $972 thousand combined), Blanket Purchase Agreement SS02164C012 (6 task orders, $859 thousand combined), and Blanket Purchase Agreement SS10251120004 (17 task orders, $93 thousand combined). Representative recent awards include a June 2026 BPA call for 1,545 independent case reviews with a ceiling of $157,400.80 and June 30, 2027 completion, an April 2026 call for case file reviews with a ceiling of $31,468.10, and an April 2025 call for 420 independent case reviews valued at $164,446.20. All work is firm fixed price with no set-aside applied to recent calls.

Activity has been sporadic: one award in 2022, one in 2023, one in 2024, two in 2025, and two in 2026. Combined potential value across all 55 awards is $11.5 million, with $3.6 million (32%) obligated to date. Only one award faces ultimate completion inside the next twenty-four months ($157 thousand potential value), creating minimal near-term recompete exposure. The vendor's footprint is narrow by design—single-customer, single-agency medical consulting specialization with no diversification into other federal customers, contract vehicles, or business lines.